Drug Profile
Research programme: MCP1 splice variant - Compugen
Alternative Names: CGEN-54; Research programme: monocyte chemoattractant protein 1 splice variant - CompugenLatest Information Update: 03 Sep 2009
Price :
$50
*
At a glance
- Originator Compugen
- Class
- Mechanism of Action CCR2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Inflammation
Most Recent Events
- 01 Nov 2006 Preclinical trials in Inflammation in Israel (unspecified route)